There is a lot of focus on the 10-year Treasury yield thanks to comments from President Trump and Treasury Secretary Bessent.

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

Providing diverse exposure to innovative tech companies, ARK Innovation ETF is ideal for long-term growth investors.